Comparison of Reintervention Rates for Type 1 and Type 2 Uterine Fibroids Treated With <scp>HIFU</scp> Ablation With Varying Non‐Perfused Volume Ratios to That With <scp>TCRM</scp>
HIFU emerges as an effective and reliable treatment modality for large type 1 and type 2 uterine fibroids, providing a viable non-invasive alternative for their management. NPVR ≥70% can serve as a technical criterion for successful operation.
Authors
- Tao Tan
- Liang Hu (ORCID: https://orcid.org/0000-0001-6984-834X)
- Jinfeng Lin
- Meijie Yang (ORCID: https://orcid.org/0000-0001-5890-7324)
- Shuang Li (ORCID: https://orcid.org/0000-0002-9193-0320)
- Zhiyun Yang (ORCID: https://orcid.org/0009-0007-4889-1411)
- Jinyun Chen (ORCID: https://orcid.org/0000-0002-6818-7145)
Institutions
- Chongqing University (CN)
- Chengdu Women's and Children's Central Hospital (CN)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Ultrasound in Medicine
- Published
- 2025-08-05
- DOI
- https://doi.org/10.1002/jum.70011
- Citations
- 1
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Chongqing Science and Technology Commission